First Neurontin trial begins 
By:
Nora Tooher
Published: July 29, 2009
Tags: Neurontin
BOSTON – Addressing jurors in the first Neurontin suicide trial, plaintiffs’ lawyer Mark Lanier asserted that drug maker Pfizer knew the anti-epilepsy medication increased the risk of suicide, but intentionally marketed off-label uses to boost the drug’s sales.
Pfizer faces first trial on Neurontin suicide claim
By:
Pat Murphy
Published: July 27, 2009
Tags: Neurontin
Pfizer, Inc., the world’s biggest drugmaker, goes to trial today on claims its epilepsy medication Neurontin increases the risk of suicide, in a case the judge called “very tough” for the plaintiffs to win. The trial will be the first of what plaintiffs’ lawyers say are about 1,200 cases.
NEW FREE WHITE PAPER: E-Discovery
This FREE e-report brought to you by Lawyers USA contains the latest tips for conducting thorough and successful electronic discovery for your trial in 2012. We’ve analyzed the latest court rulings and trends in e-discovery to help you and your clients avoid sanctions and win your case.
Click here to get your free White Paper today!
